HON vs IBM
Side-by-side quantum stock comparison: market cap, share price, classification, and thesis.
Market cap, head to head
Stat-by-stat
| Metric | HON | IBM |
|---|---|---|
| Type | Diversified | Diversified |
| Segment | Hardware | Hardware + Software |
| Exchange | NASDAQ | NYSE |
| Country | US | US |
| Market cap | $71.74B | $270.27B |
| Share price | $226.42 | $287.56 |
| Employees | 102,000 | 270,300 |
| Sector | Industrials | Technology |
| Industry | Conglomerates | Information Technology Services |
Quantum thesis
Honeywell spun its quantum hardware group into Quantinuum, a privately held trapped-ion company in which Honeywell holds a majority stake. Buying HON is the only public-market way to own Quantinuum equity, but quantum is a small fraction of Honeywell's diversified industrial revenue, so the exposure is highly diluted.
Full HON page →Quantum thesis
IBM runs the most mature commercial quantum program of any public company. IBM Quantum operates a fleet of superconducting processors over the cloud, publishes a detailed hardware roadmap, and ships Qiskit, the most widely used open-source quantum software stack. Quantum is a tiny share of IBM revenue, but no other diversified bet has more direct quantum exposure or a longer track record.
Full IBM page →